ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use

RTTNews | 347天前
ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use

(RTTNews) - Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.

Kionex Suspension is the only commercially available therapeutically equivalent to the reference listed drug (RLD) SPS Suspension for Oral or Rectal use.

The U.S. annual sales for Sodium Polystyrene Sulfonate Oral / Rectal Suspension total approximately $30.3 million, based on March 2024 moving annual total (MAT) IQVIA data.

read more
Yen Slides Against Majors

Yen Slides Against Majors

The Japanese yen weakened against other major currencies in the Asian session on Friday.
RTTNews | 1小時30分鐘前
European Economic News Preview: Eurozone Inflation, Unemployment Data Due

European Economic News Preview: Eurozone Inflation, Unemployment Data Due

Flash inflation, unemployment and final factory Purchasing Managers' survey results from the euro area are due on Friday, headlining a busy day for the European economic news. At 3.15 am ET, Spain's manufacturing PMI survey data is due. Economists forecast the index to rise to 50.0 in April from 49.5 in March.
RTTNews | 2小時22分鐘前